戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 unresolved, ELSI issues posed by portable neuroimaging: (1) informed consent; (2) privacy; (3) capacity to accurately com
2 a potential threat to tribal services eligibility, 4) broad informed consent language, and 5) vague definitions of data a
3 mologists should use evidence-based practices and a careful informed consent process when choosing intravitreal antibioti
4 eral risks and benefits; 11% reported conducting a complete informed consent discussion for each procedure.
5 ntial for disclosure of genetic information; and a detailed informed consent process.
6 uded patients less than 72 hours after intubation following informed consent from their next of kin.
7 t the care pathway of overdoses and provide information for informed consent.
8 ssary to further explore what constitutes best practice for informed consent in critical care.
9                      The study qualified for exception from informed consent (21 Code of Federal Regulations 50.24).
10 ed this HIPAA-compliant protocol, and all participants gave informed consent.
11 d using a standardized questionnaire, and all patients gave informed consent.
12 ulation, which included randomly assigned patients who gave informed consent and excluded those without 6-month outcome m
13 anagement of miscarriage, and were willing and able to give informed consent.
14 y-two of 53 consecutive patients were enrolled after giving informed consent and fulfilling study entry criteria.
15 with acute asthma exacerbations were recruited after giving informed consent.
16  used to facilitate donor/recipient matching and to improve informed consent.
17 fic cultural challenges related to surgical care, including informed consent, pain management, difficult diagnoses and re
18 stitutional review board, but may not require patient-level informed consent when the interventions being tested can be c
19 bone marrow were collected from the patient after obtaining informed consent.
20    Key inclusion criteria were age 1-4 years at the time of informed consent; fasting serum phosphorus concentration of l
21 tability Act-compliant retrospective study, and a waiver of informed consent was received.
22 e such activities do not require further ethical oversight, informed consent, or protections for vulnerable persons or co
23  risk factors is a graphical template for obtaining patient informed consent in the future.
24 sties to develop a chart for a personalized written patient informed consent.
25 se determinations have important implications for patients' informed consent rights, clinicians' employment rights, and m
26  the most common complications influencing the preoperative informed consent were: smoking, operative technique, resectio
27   The genetic evaluation framework included optimal pretest informed consent, post-test discussion, cascade testing, and
28 oncerns related to the adequacy of participant protections, informed consent, and participant understanding of the risks
29 esent to the ED and are clinically stable enough to provide informed consent.
30 oached for participation in the ICU, of which 1458 provided informed consent.
31 ed to reside in the area for more than 1 year, and provided informed consent.
32                                   All patients who provided informed consent were included in the safety analysis.
33 s bedside and research staff safety, infection control, the informed consent model, protocol complexity, data collection,
34 iew board approved this retrospective study, and waived the informed consent requirement.
35 rospectively randomized in a 1:1 fashion under exception to informed consent regulations to early coronary angiography ve
36    A minority (26%) felt confident that they obtained valid informed consent for critical care procedures with the use of
37 ng the clinician to order an Affirm test were enrolled with informed consent for the collection of additional specimens.
38                                                     Written informed consent was provided by all women who entered the tr
39 tudy was approved by the local ethics committee and written informed consent was obtained from all participants.
40 d, which was approved by the local ethics board and written informed consent was obtained from all participants.
41 y concerns, and practical issues in recruitment and written informed consent.
42 accination between 10 and 11 October 2015 following written informed consent.
43 nation between October 10th and 11th 2015 following written informed consent.
44                          Methods: All patients gave written informed consent for further utility of the biologic material
45 cipants, aged 60-75 years, 46% (138) male, who gave written informed consent, for 4-year periods following randomisation.
46  were diagnosed with paracetamol overdose, and gave written informed consent.
47 active labour, aged 15 years or older, and provided written informed consent on behalf of themselves and their neonate.
48                 Women aged 18-60 years who provided written informed consent, resided in the participating cluster catchm
49 l was obtained, and all recruited subjects provided written informed consent.
50 l patients in the extended follow-up provided their written informed consent (data cutoff: December 31, 2016).